Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cochrane Database of Systematic Reviews, 2022, 8, S. CD014383-
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2022
- Ereignis
-
Veröffentlichung
- (wo)
-
Hoboken
- (wer)
-
Wiley
- (wann)
-
2022
- Urheber
-
Bighelli, Irene
Rodolico, Alessandro
Siafis, Spyridon
Samara, Myrto T.
Hansen, Wulf-Peter
Salomone, Salvatore
Aguglia, Eugenio
Cutrufelli, Pierfelice
Bauer, Ingrid
Baeckers, Lio
Leucht, Stefan
- DOI
-
10.1002/14651858.cd014383.pub2
- URN
-
urn:nbn:de:bvb:384-opus4-985432
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bighelli, Irene
- Rodolico, Alessandro
- Siafis, Spyridon
- Samara, Myrto T.
- Hansen, Wulf-Peter
- Salomone, Salvatore
- Aguglia, Eugenio
- Cutrufelli, Pierfelice
- Bauer, Ingrid
- Baeckers, Lio
- Leucht, Stefan
- Universität Augsburg
- Wiley
Entstanden
- 2022
Ähnliche Objekte (12)
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Antipsychotic polypharmacy prescribing and risk of hospital readmission
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Antipsychotic polypharmacy in a regional health service: a population-based study
Polypharmacy in schizophrenia - therapeutic option or a sign of despair?
Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process
Ready-to-run Delphi 3.0 algorithms, Buch.
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Antipsychotic polypharmacy prescribing and risk of hospital readmission
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Antipsychotic polypharmacy in a regional health service: a population-based study
Polypharmacy in schizophrenia - therapeutic option or a sign of despair?
Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process
Ready-to-run Delphi 3.0 algorithms, Buch.
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Antipsychotic polypharmacy prescribing and risk of hospital readmission
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Antipsychotic polypharmacy in a regional health service: a population-based study
Polypharmacy in schizophrenia - therapeutic option or a sign of despair?
Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process